Berres Jennifer

SVP & Chief Human Res. Officer

Berres Jennifer has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 12, 2026.

On the most recent filing, Berres Jennifer is listed as SVP & Chief Human Res. Officer at HCA Healthcare, Inc. Inside the rolling window, Berres Jennifer reported no open-market purchases and 1 open-market sale totaling $4.1M in HCA.

Companies traded

Other insiders at HCA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$4.1M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
HCASale$4.1MFeb 12SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Berres Jennifer made?

Berres Jennifer has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.

Which companies does Berres Jennifer trade?

Berres Jennifer has filed SEC Form 4 disclosures for 1 company, including HCA.

When was Berres Jennifer's most recent SEC Form 4 filing?

Berres Jennifer's most recent SEC Form 4 filing on Tracefour is dated Feb 12, 2026.

What is Berres Jennifer's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Berres Jennifer is listed as SVP & Chief Human Res. Officer.

What is Berres Jennifer's total buy and sell value in the current window?

Inside the rolling retention window, Berres Jennifer bought $0 and sold $4.1M based on SEC Form 4 filings.

What was Berres Jennifer's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 8,020 HCA shares on 2026-02-11, worth $4.1M, per SEC Form 4 filings.